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T – Abstract 
Objective 
The number of elderly patients with aneurysmal subarachnoid hemorrhage (aSAH) is 
increasing but their prognosis remains unsatisfactory. Our aim is to determine which patients 
are most likely to benefit from active treatment.  
Methods 
Between 1980 and 2008, 289 patients aged ≥70 years were treated for aSAH at the 
Department of Neurosurgery, Helsinki University Central Hospital (HUCH). We assessed the 
functional outcome at three months and the mortality at one year after aSAH. 
Results 
Only 30% of actively treated patients had favorable outcome with a one year fatality rate of 
36%. Predictive factors of favorable outcome included good initial clinical grade and the 
absence of intraventricular and intracerebral hemorrhage. Medical complications were 
associated with unfavorable outcome. 
Conclusion 
Elderly aSAH patients have often poor prognosis. Severity of the SAH is the most important 
determinant of outcome. Active treatment decreases mortality and should be offered to 
patients with good initial clinical condition. 
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1 Introduction 
Advanced age is an important risk factor for poor outcome in patients who suffer 
subarachnoid hemorrhage (SAH) caused by the rupture of an intracranial 
aneurysm (1). The incidence of aneurysmal SAH (aSAH) increases with age (2).  
Since the 1970s, the mean age of aSAH patients has been increasing. Nowadays, the 
mean age is closer to 60 than 50 years of age (3). In the meantime the percentage 
of senior citizens within the general population is growing quickly in many 
Western countries, so patients aged ≥70 years may comprise as much as 20 -25% 
of all aSAH cases (4). In Finland, with a population of 5 million, this corresponds to 
an estimate of more than 200 cases per year (3). Therefore, the management of 
aSAH in the elderly has become an important issue. 
 
Treatment of elderly patients with SAH is challenging because of pre-existing 
medical conditions and multiple medications. Elderly SAH patients tend to be in 
worse condition on admission, they have a thicker subarachnoid blood clot on the 
computed tomography (CT) scan (5), and they develop delayed neurological 
deficits and hydrocephalus more frequently compared to younger patients (6). In 
addition, the elderly patients have a shorter life expectancy and decreased 
neuronal plasticity to help them recover. As a result, the outcome of elderly aSAH 
patients is in many cases poorer compared to their younger peers. However, with 
active treatment some elderly patients, especially those in good initial clinical 
condition, can expect similar outcome as younger patients (7,8). It is still unclear 
which occlusion method for the ruptured aneurysm would be more favorable in 
the elderly, microneurosurgical clipping or endovascular coiling.  
 
This retrospective study reflects the management of aSAH in the elderly over the 
past three decades in Finland. We analyzed the characteristics of 289 aSAH 
patients aged ≥70 years treated in Helsinki University Central Hospital, 
Department of Neurosurgery during 1980-2008. We focused on finding predictive 
factors related to good and poor outcome. Furthermore, we defined more clearly 
the relationship between clinical characteristics and outcome after aSAH in elderly 
patients. Our aim was to identify those patients who would benefit from active 
treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Patients and Methods 
Helsinki Cerebral Aneurysm database contains data of all intracranial aneurysm 
patients admitted to Helsinki University Central Hospital (HUCH) in 1937-2008. 
HUCH is the largest neurosurgical center in Finland and alone covers a population 
of 1.8 million in Southern Finland. The total of nearly 9000 aneurysm patients 
makes it one of the largest databases of its kind in the world. From the database, 
we retrieved the data of 413 patients who were ≥70 years old at the time of 
diagnosis, and who were admitted to HUCH between 1.1.1980 – 31.12.2008. 
During this period of 29 years CT imaging was routine in HUCH. These 413 
patients represent 8% of all aneurysm patients treated in HUCH during the same 
period. Among the 413 patients, 17 (4%) had fusiform or dissecting aneurysms 
and they were excluded. Of the remaining 396 saccular aneurysm patients, 107 
were treated for unruptured aneurysm(s) only (Figure 1). In this study we focused 
on the 289 patients who were treated for aSAH. They represent 7% of all aSAH 
patients treated in HUCH during this period.  
Both clinical and radiological data of the patients were reviewed. The diagnosis of 
SAH was confirmed by CT scan or lumbar puncture. The aneurysms were identified 
using digital subtraction angiography (DSA), CT angiography (CTA) or magnetic 
resonance angiography (MRA). Severity of the subarachnoid hemorrhage was 
expressed using the Fisher scale (9). The initial clinical condition was assessed 
using Hunt & Hess (HH) and World Federation of Neurosurgical Societies (WFNS) 
grading scales (10,11). The initial clinical condition was categorized according to 
Hunt and Hess scale as good (grade I-III) or poor (grade IV-V).  
 Figure 1. Patient selection.  
 
2.1 Patients 
Characteristics of the 289 patients with aSAH are shown in Table 1. The mean age 
at time of diagnosis was 75 years (median 75, range 70-92 years). The majority of 
the patients were female (78%). Half of the patients had a history of hypertension 
and a quarter had cardiac disease. Every tenth patient had suffered a stroke or 
transient ischemic attack prior to the aSAH and just as many were taking statins. 
Almost a fifth of the patients had aspirin medication (51 cases, 18%) but only 15 
patients (5%) were on warfarin.  
2.2 Aneurysms 
Altogether, 397 aneurysms were found in the 289 patients with aSAH. There were 
211 (73%) patients with a single aneurysm, 54 (19%) with two aneurysms, 18 
(6%) with three aneurysms and 6 (2%) with four aneurysms. In other words, 
multiple aneurysms were found in 78 (27%) cases.  
Ruptured aneurysms were divided into four groups according to size. Most of the 
ruptured aneurysms (240 cases, 83%) were <15mm in size, the median being 
8mm. Four patients (1%) had rupture of a giant aneurysm (≥25mm).  
The location of the ruptured aneurysm was divided into five groups: internal 
carotid artery (ICA), middle cerebral artery (MCA), anterior communicating artery 
and proximal anterior cerebral artery (AcomA), pericallosal artery, and posterior 
circulation (including vertebral, basilar, cerebellar and posterior cerebral arteries). 
The most common locations for the ruptured aneurysms were the AcomA, MCA 
and ICA which accounted for 82 (28%), 81 (27%) and 79 (27%) cases, 
respectively. 
 
2.3 Treatment  
Microneurosurgical clipping was the treatment of choice for 206 patients (71%), 
35 patients (12%) had endovascular embolization of the ruptured aneurysm, and 
37 patients (13%) were treated conservatively. The most common reason for 
choosing conservative treatment was expected poor prognosis because of poor 
initial clinical grade: this was the case in 17 (46%) conservatively treated patients. 
Other reasons for conservative treatment included old age in eight (22%) cases, 
death before treatment in five (14%) cases and patient refusing surgical treatment 
in three (8%) cases. 
 
2.4 Follow-up  
The Glasgow Outcome Score (GOS) was used to evaluate functional outcome at 
three months after the SAH (12). Outcome was divided into two categories: 
favorable (GOS 4-5); and unfavorable (GOS 1-3). The functional outcome was 
evaluated at three months for 205 patients. Eighty one patients had no follow-up 
after discharge and data was missing in three patients. Mortality was evaluated in 
both conservatively and actively treated group at one year after the acute onset of 
aSAH. The follow-up for the conservatively treated patients was based on mortality 
since only 24% (n=9) were evaluated clinically at 3 months. Death certificates 
were reviewed and vital status data at the end of the year 2008 were obtained 
from the Population Register Center of Finland, which contains information on all 
the people living in Finland.  
Table 1. Characteristics of 289 patients aged ≥70 years with SAH caused by the 
rupture of a saccular aneurysm. 
 n (%) 
Total 289 (100)  
Sex  
Female 226 (78) 
Male 63 (22) 
Medical history   
Hypertension 142 (49) 
Cardiac disease 71 (25) 
Respiratory disease 23 (8)  
Current smoker 27 (9)  
Prior medication   
Oral anticoagulant 15 (5)  
Aspirin 51 (18) 
LMWH 1 (0) 
Clopidogrel 2 (1) 
Statin 31 (11) 
Prior stroke or TIA  31 (11) 
Prior functional status   
Independent 268 (93) 
Dependent 6 (2) 
Data missing 15 (5)  
Number of aneurysms  
1 211 (73) 
≥2 78 (27) 
 
 
Location of ruptured aneurysm 
 
ICA 79 (27) 
MCA 81 (28) 
AcomA & A1  82 (28) 
Pericallosal artery 14 (5)  
Posterior circulation 33 (11) 
Size of ruptured aneurysm   
≤7mm 130 (45) 
7-13mm 103 (36) 
>13mm 40 (14) 
Data missing 16 (6)  
Treatment  
Clipping 206 (71) 
Embolization 35 (12) 
Other 11 (4)  
Conservative treatment 37 (13) 
Initial HH   
1 17 (6)  
2 105 (36) 
3 64 (22) 
4 66 (23) 
5 30 (10) 
Data missing 7 (2) 
Initial WFNS   
1 121 (42) 
2 56 (19) 
3 20 (7)  
4 41 (14) 
5 44 (15) 
Data missing 7 (2) 
CT Fisher scale   
No blood  10 (3)  
Blood <1mm 29 (10) 
Blood ≥1mm 80 (28) 
ICH and/or IVH ± SAH 139 (48) 
Data missing 31 (11) 
CT findings  
ICH 93 (32) 
IVH 85 (29) 
ICH and IVH 41 (14) 
SDH 12 (4)  
Acute hydrocephalus 135 (47) 
 
LMWH, low molecular weight heparin; TIA, transient ischemic attack; ICA, internal 
carotid artery; MCA, middle cerebral artery; AcomA, anterior communicating 
artery; A1, first segment of the anterior cerebral artery; HH, Hunt & Hess grade; 
WFNS, World Federation of Neurosurgical Societies grading scale; CT, computed 
tomography; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; 
SDH, subdural hematoma 
 
2.5 Statistical methods 
Data analysis was performed using IBM SPSS Statistics 20 software. The 
significance level was set at p≤0.05. The Fisher’s exact test was used to analyze the 
relationships between prognostic factors and outcome. 
The aneurysm database has approval of the Ethics Committee of the HUCH (D 
number 469/E0/04).  
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Results  
Over the study period, there was a clear trend for an increase in the proportion of 
≥70 year old patients with aSAH admitted to the Department of Neurosurgery in 
HUCH. During the first half of the study period in 1980-1993, there were only 13 
admissions (4%) compared to 276 admissions (96%) in the second half in 1994-
2007. During the 1980’s there were virtually no elderly aSAH patients admitted to 
HUCH at all and it wasn’t until the late 1990’s that the proportion of elderly 
patients started to grow reaching an average of 14% during 2000-2007.  
 
 
Figure 2. Bar graph showing an increase in the proportion of elderly patients with 
aneurysmal subarachnoid hemorrhage admitted in 1980-2007. 
 
3.1 Outcome after active treatment 
Actively (n=252) and conservatively (n=37) treated patients were analyzed as 
separate groups, with main focus on the active treatment.  Of the 252 actively 
treated patients with aSAH, 30% (n=76) achieved favorable outcome and 69% 
(n=174) had unfavorable outcome at the three month follow-up. The fatality rate 
at three months was 30% (76 deaths).  
The fatality rate at one year after discharge was 36% (91 deaths). The most 
common cause of death during the first year was aSAH accounting for 86% (n=78) 
deaths. Five patients (6%) died of cardiovascular causes and three patients (3%) 
died of cerebrovascular disease other than aSAH. 
The median duration of postoperative neurosurgical care was 5 days at the ICU 
and 14 days at the ward before transfer to another hospital.  There were a total of 
21 (8%) in-hospital deaths, all caused by SAH. At discharge, 90% (n=228) patients 
had unfavorable outcome (GOS 1-3) and only 8% (n=20) patients had favorable 
outcome (GOS 4-5). 
Preoperative rebleeding of the ruptured aneurysm was diagnosed in 17% (n=43) 
of patients despite early treatment. The majority of patients (71%, n=175) had 
their aneurysm operated 0-3 days after the onset of aSAH. The median delay for 
operation after bleeding was one day. There were three patients who had their 
aneurysm operated more than a year after SAH because their primary treatment 
had taken place in a hospital excluded from this study. Surprisingly, the occurrence 
of rebleeding did not demonstrate a significant effect on outcome. 
Clinically relevant vasospasm occurred in 13% (n=33) of patients. These patients 
tended to have more often unfavorable outcome compared to patients who 
avoided vasospasm, 79% (n=26) and 68% (n=148), respectfully. This result was 
not statistically significant. 
Hydrocephalus requiring a permanent shunt developed in 22% (n=55) patients. 
These patients had more often unfavorable outcome compared to patients who did 
not require insertion of a shunt: unfavorable outcome in 87% (n=48) and 63% 
(n=117) cases, respectfully (p=0.001). The shunt was inserted usually weeks after 
aneurysm rupture (median 22 days after SAH). 
 
3.1.2 Age and outcome  
Age and sex of patient did demonstrate a significant effect on outcome. The median 
age was 74 years for patients with favorable outcome and 75 years for patients 
with unfavorable outcome. Six patients were ≥85 years of age at admission: four of 
them in good initial condition (HH I-III) and two in poor initial condition (HH IV-
V). All six patients aged ≥85 years had unfavorable outcome.  
 
3.1.3 Medical history  
A history of stroke or transient ischemic attack appeared to be a risk factor for 
unfavorable outcome. Unfavorable outcome was seen in 89% (23/26) of these 
patients compared to 66% (141/214) in other patients (p=0.049).  
A history of hypertension, a known risk factor for SAH, was seen equally often both 
in patients with favorable as well as in patients with unfavorable outcome, 46% 
and 49% respectively. The presence of cardiac disease, chronic respiratory disease 
or other illness did not affect outcome.  
Prior medication of oral anticoagulant, aspirin, low molecular weight heparin, 
clopidogrel or statins was not related to outcome. Warfarin treatment seemed to 
be a risk factor for the presence of intracerebral or intraventricular blood in CT 
scan (Fisher grade 4). However, this result was not statistically significant. Only 
5% (n=13) of patients were on warfarin treatment. 
 
3.1.4 Clinical grade  
Initial clinical grade was clearly associated with outcome (p<0.001). At admission 
66% (n=166) patients were in good clinical condition (Hunt and Hess grade I-III) 
and 33% (n=83) were in poor clinical condition (grade IV-V). This data was not 
available for seven patients. 
Of the 166 patients with a good initial clinical grade, 39% (n=64) had favorable 
outcome and 60% (n=100) had unfavorable outcome. Of the 83 patients with a 
poor initial clinical grade, only 13% (n=11) had favorable outcome and 87% 
(n=72) had unfavorable outcome. Poor initial clinical grade seemed to double the 
risk of death at the three month follow-up. 
Patients with a good initial clinical grade of WFNS I (43%, n=108) had a 50% 
chance of achieving favorable outcome. Of the 140 patients with an initial WFNS 
grade II-V, favorable outcome was achieved in only 16% (n=22) of cases.  
Table 2. Outcome of 249 patients at three months with respect to their initial 
clinical condition.  
GOS 
HH 
Good 
recovery 
Moderate 
disability 
Severe 
disability 
Vegetative 
state 
Death 
Total n 
(%) 
I 11 2 2 0 0 15 (6) 
II 33 7 29 5 20 95 (38) 
III 7 4 22 7 16 57 (23) 
IV 1 5 22 5 28 62 (25) 
V 2 2 5 1 10 20 (8) 
Total n 
(%) 
54 (22) 20(8) 80 (32) 18 (7) 
74 
(30) 
249 
(100) 
 
 
3.1.5 ICH and IVH 
The amount of blood in the subarachnoid space represented by the Fisher scale 
and CT findings were strong predictors of outcome at the three month follow-up. 
Patients with intracerebral hemorrhage (ICH) (n=75) had favorable outcome in 
only 19% (n=14) of cases compared to 36% (n=53) of patients without ICH 
(n=149) (p=0.01).  
Intraventricular hemorrhage (IVH) (n=69) was also a risk factor for unfavorable 
outcome. Only 15% (n=10) of patients with IVH achieved favorable outcome in 
comparison with 37% (n=57) of patients without IVH (n=155) (p=0.001).  
Patients with both ICH and IVH (n=30) had favorable outcome in only 10% (n=3) 
cases (p=0.015). Patients with neither ICH nor IVH (n=110) had favorable outcome 
in 42% (n=46) of cases (p<0.001). 
Table 3. The presence of intracerebral hemorrhage or intraventricular hemorrhage 
related to outcome at three month follow-up. 
GOS 
Good 
recovery 
Moderate 
disability 
Severe 
disability 
Vegetative 
state 
Death 
Total n 
(%) 
ICH 6 8 25 8 28 75 (30) 
IVH 6 4 20 8 31 69 (27) 
ICH and 
IVH 
1 2 9 5 13 30 (12) 
No 
ICH/IVH 
38 8 34 5 24 
109 
(43) 
All 
patients 
55 (22) 20  (8) 80 (32) 18 (7) 76 (30) 
252 
(100) 
 
 
3.1.6 Aneurysm size and location 
Neither aneurysm size nor location had significant effect on outcome. The median 
aneurysm size was 8 mm in patients with favorable outcome and 7 mm in patients 
with unfavorable outcome. The number of aneurysms detected at the time of 
diagnosis of aSAH did not have a significant effect on outcome.  
 
3.1.7 Clipping vs. coiling 
Patients who had their aneurysm clipped tended to be in better initial clinical 
condition compared to the endovascularly treated patients. In the clipped group, 
68% (n=141) had good and 32% (n=32) poor initial clinical grade whereas in the 
coiled group the numbers were 54% (n=19) and 43% (n=15), respectively.  
Also treatment outcome seemed to be more often favorable in patients treated 
with microneurosurgical clipping compared to patients treated with endovascular 
techniques, 33% (n=69) and 11% (n=4) cases respectively.  
The distribution of aneurysm location was different in endovascularly versus 
microneurosurgically treated patients. In endovascularly treated patients, 60% 
(n=21) of aneurysms were located in the internal carotid artery compared to 22% 
(n=46) in clipped patients. In clipped patients, 31% (n=64) had an aneurysm in the 
middle cerebral artery compared to 6% (n=2) in the endovascularly treated 
patients (p<0.001). 
Table 4. Location of the ruptured aneurysm in clipped and coiled patients. 
 ICA MCA A Pericall P 
Total n 
(%) 
Clipped 46 64 66 10 22 208 (83) 
Coiled 21 2 6 1 5 35 (14) 
Other 3 3 3 0 0 9 (4) 
All 70 (28) 69 (27) 75 (30) 11 (4) 27 (11) 252 (100) 
 
ICA, internal carotid artery; MCA, middle cerebral artery; A, anterior 
communicating artery/anterior cerebral artery; Pericall, pericallosal artery; P, 
posterior circulation 
3.1.8 Medical complications 
Medical complications were common in the elderly aSAH patients, yet unaffected 
by the type of treatment. The most common medical complication was pneumonia 
which developed in over half of the actively treated patients (56%, n=142). 
Patients with poor initial clinical grade (HH IV-V) had more often postoperative 
pneumonia compared to patients with good initial clinical grade (HH I-III): 82% 
(n=68) and 45% (n=74), respectively (p<0.001). Patients who avoided 
postoperative pneumonia achieved favorable outcome in 50% (n=54) cases 
compared to 15% (n=21) of cases that had pneumonia (p<0.001).  
Of all actively treated aSAH patients, 46% (n=115) suffered postoperative cerebral 
infarction. Patients with poor initial clinical grade tended to develop this 
complication more often than others, but this result was not statistically 
significant. Patients who avoided postoperative cerebral infarction had favorable 
outcome in 47% (n=58) cases compared to 13% (n=15) of the patients who 
suffered this complication (p<0.001). 
Since the initial clinical grade seemed to be associated with occurrence of 
postoperative pneumonia and cerebral infarction, it is not surprising that these 
complications were also associated with prolonged treatment at the ICU. The 
median stay at the ICU was two days for the patients who avoided pneumonia and 
seven days for the patients who had pneumonia. In the case of brain infarction the 
numbers were four and seven days, respectively.  
 
3.2 Conservatively treated patients 
Outcome at discharge seemed to be better in conservatively than actively treated 
patients. Of the 37 conservatively treated patients, 16% (n=6) had favorable 
outcome and 73% (n=27) had unfavorable outcome at discharge compared to 9% 
(n=22) and 90% (n=226) in the actively treated group, respectively. Data on four 
patients was not available. Of the six patients with favorable outcome at discharge, 
five had been treated conservatively because of old age and one patient had 
refused treatment. Four of them died of SAH later on and three survived for more 
than five years. 
Almost half of the conservatively treated patients (46%, n=17) died in hospital 
compared to 8% (n=19) of the actively treated group.  The fatality rate was 68% 
(n=25) at 3 months compared to 30% (n=76) in the actively treated group. At one 
year the fatality rate had risen to 78% (n=29) compared to 36% (n=91) in the 
actively treated group.  
The conservatively treated patients had the same median age at admission as the 
actively treated patients.  The median aneurysm size was slightly larger (10 mm) 
compared to actively treated patients (8 mm). We did not find any significant 
differences between these two patient groups regarding medical history, prior 
medication, aneurysm number or location. However, the actively treated patients 
tended to be more often in good initial clinical condition compared to the 
conservatively treated group. The conservatively treated patients seemed to have 
more often ICH and IVH in CT scan compared to actively treated group.  
Table 6. Comparison of conservatively and actively treated patients.  
n (%) 
Conservative 
treatment 
Active treatment 
Initial good 17 (46) 166 (66) 
Initial poor 14 (38) 83 (33) 
ICH 18 (49) 75 (30) 
IVH 16 (43) 69 (27) 
ICH and IVH 11 (30) 30 (12) 
 
Initial clinical grade divided in two groups: good (Hunt and Hess I-III) and poor 
(Hunt and Hess IV-V); ICH, intracerebral hemorrhage; IVH, intraventricular 
hemorrhage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 Discussion 
The mean age of aSAH patients and the proportion of the elderly population in 
many countries are increasing (3,13). Overall outcome of elderly aSAH patients has 
not improved over the years in spite of technological innovations (14-16). We 
found that the rupture of an intracranial aneurysm has often devastating 
consequences in the elderly despite active treatment. In our study, the main 
determinant of outcome after aSAH was the intensity of the hemorrhage described 
by CT findings and the initial clinical grade of the patient. Despite the frequency of 
medical complications, some of the patients achieved a favorable outcome. 
However, the outcome was most often unsatisfactory and difficult to predict.  
 
4.1 Age and aSAH 
In our study of 289 elderly patients with aSAH, there was a clear increase in the 
proportion of patients aged 70 years or older during 1980-2007. In our opinion, 
this reflects (a) the change of attitude in the treatment of SAH from conservative to 
active operative treatment over the study period as well as (b) an increase in the 
number of elderly people in the western world, including Finland (17). In Finland 
the proportion of the population aged ≥70 years is estimated to increase from 12% 
to 18% by year 2020 (13). On the other hand, the incidence of aSAH has been 
shown to be stable over the last decades (18). 
At the end of our study period, the elderly accounted for 14% of all aSAH patients. 
This percentage is only half of what was found in Japanese studies (19,20) but 
similar to a European study (21). We expect that the proportion of elderly aSAH 
patients will rise in Finland during the next decades. 
We found aSAH to be more frequent in elderly women than men. In fact, women 
outnumbered men by 3.5 to 1 probably because of female preponderance in this 
age group due to higher life expectancy. This finding is in accordance with other 
studies (5,22). 
 
4.2 Age and outcome 
Advanced age is an independent risk factor for poor outcome in aSAH patients 
(1,6). We found that the overall outcome in elderly aSAH patients was in most 
cases unsatisfactory: only 30% achieved favorable outcome in this study despite 
active treatment. This result is close to that found in the ISAT study, a more 
selected study population than ours, where 36% of the corresponding age group 
achieved favorable outcome (1). In surgical studies where the patients are 
selected, it has been reported that 39.6-60% of patients have favorable outcome 
(20,21). In our study, all six patients aged 85 years or older had unfavorable 
outcome. Based on this finding, we would recommend limiting active treatment for 
patients above 85 years to only highly selected cases.  
It has been pointed out that advanced age alone is not a contradiction to surgical 
treatment of aSAH in the elderly (5). Fridriksson et al. reported 74% of good 
results in patients whose initial Hunt and Hess clinical grade was I or II, with these 
results coming very close to those obtained in younger populations (4). In our 
study, only 48% of actively treated patients with Hunt and Hess clinical grade I or 
II had favorable outcome at three months. This difference in favorable outcome is 
possibly due to a more selected study population in the Swedish study. In our 
opinion, good grade elderly patients should be still treated actively. 
Poor grade elderly aSAH patients have been shown to have a poor outcome despite 
treatment (23). In our study, poor grade elderly aSAH patients had favorable 
outcome in only 13% of cases. As with very old age, poor initial condition should 
be considered a relative contraindication for active treatment, and should be 
reserved only for selected cases. 
 
4.3 Factors related to favorable outcome 
The preoperative condition has been shown to be the most important predictor of 
aSAH outcome (23). We found that factors for favorable outcome at three month 
follow-up included an initial clinical grade of WFNS I, the absence of ICH and IVH in 
CT scan and avoidance of postoperative pneumonia and cerebral infarction. 
Therefore, it seems that the most important factor that determines outcome in 
elderly aSAH patients is the severity of SAH which largely determines both the 
initial clinical grade and the amount of blood and findings in the CT scan. In our 
opinion, active treatment should be offered to all elderly aSAH patients who have 
the chance of recovering to functional independency. The patients who have a 
good initial clinical grade of WFNS I or absence of ICH and IVH in CT scan are the 
best candidates. 
 
4.4 Aneurysm location and size and outcome 
In our study, the size or location of the aneurysm was not associated with outcome.  
However, the results are inconsistent in previous studies on the subject (24).  
Patient age seems to have no effect on the size or location of intracranial 
aneurysms (19).  
 
4.5 Medical history and outcome 
 The preexisting medical condition, compromised cerebral circulation and neural 
plasticity with advancing age may contribute to an unfavorable outcome after 
aSAH in elderly patients (5,6). In our study, we found no association between the 
preexisting medical conditions and outcome. Hypertension is a known risk factor 
for aSAH and it is more frequent in elderly patients (20). However a history of 
hypertension did not demonstrate effect on outcome and this finding has been 
confirmed by another study (22).  We could not analyze the effect of alcohol abuse 
and smoking on outcome because of incomplete data. Probably, other factors than 
preexisting medical conditions are much more important in predicting outcome in 
the elderly aSAH patients. 
We did not find association between aspirin, clopidogrel, warfarin, LMWH or 
statins medication and outcome. Partly this could have been because of insufficient 
number of patients on these drugs. However, oral anticoagulants may be related to 
a more abundant hemorrhage in CT scan and they are known to increase the risk of 
intracerebral hemorrhage 7-10 fold (25). There are studies sending positive 
signals of the potential beneficial effects of statins in preventing delayed ischemic 
deficits and reducing mortality in aSAH patients (26). In our study with a small 
number of patients taking these drugs, statins were not associated with more 
favorable outcome. 
 
4.6 Factors related to unfavorable outcome 
We found that factors predicting unfavorable outcome at three month follow-up 
included: history of stroke or transient ischemic attack; poor initial clinical grade 
(HH IV-V or WFNS II-V); the presence of ICH and/or IVH in CT scan; occurrence of 
vasospasm; postoperative pneumonia; postoperative brain infarction; and 
hydrocephalus requiring permanent shunt. Several of these risk factors are linked 
to each other; severe aSAH tends to cause poor clinical grade which in turn 
predisposes to medical complications and prolonged treatment at the ICU. In these 
cases the outcome is seldom favorable.  
History of cerebrovascular disease could be a sign of reduced functional capacity 
and increased vulnerability of the brain leading to worse outcome after aSAH. 
Previous studies have demonstrated that elderly patients have more often poor 
initial clinical grade and a more abundant hemorrhage in CT scan explaining the 
worse outcome compared to younger patients (27,28).  
 
4.7 Rebleeding, vasospasm and chronic hydrocephalus 
Rebleeding of the aneurysm has been found to be more common in elderly patients 
probably due to atherosclerosis and increased stiffness of the arterial wall (6,14). 
Also, age-related cerebral atrophy and ventricular enlargement leading to 
decreased counterpressure can hypothetically predispose to rebleeding. 
In our study, rebleeding before operation occurred in 17% of patients. Lanzino et 
al. had similar results with rebleeding seen in 16% of elderly patients (6,25). 
Contrary to other studies, we could not demonstrate association between 
rebleeding and outcome. Nevertheless, early surgery can be assumed to benefit the 
elderly aSAH patients in order to prevent rebleeding and treat vasospasm more 
aggressively (6).  
The increased stiffness of the arterial wall together with the decreased 
responsiveness to spasmogenic factors in the elderly patients should result in 
decreased incidence of vasospasm compared to younger patients. However, due to 
impairment of cerebral autoregulation of the blood flow, elderly patients are more 
likely to suffer delayed neurological ischemic deficit caused by vasospasm. In our 
study, clinically relevant vasospasm occurred in 13% of patients. Ferch et al. found 
symptomatic vasospasm in 18% of patients ≥70 years (6). However, the definition 
of vasospasm can vary between studies making reliable comparison questionable.  
We found that 22% of patients developed hydrocephalus requiring shunt after 
aSAH. Many of these patients had shunt-related complications causing 
reoperations. Elderly patients are known to have higher incidence of chronic 
hydrocephalus (21). Reported incidence of hydrocephalus in elderly aSAH patients 
varies widely between 4-55% (6,29). 
 
4.8 Conservative treatment 
In conservatively treated patients with aSAH the mortality and morbidity rates are 
known to be high. In a Swedish study of elderly aSAH patients, 75% suffered 
morbidity and mortality with more than half of the patients dying within the first 
three months (21). We had similar results with 73% of conservatively treated 
patients having unfavorable outcome at discharge. However, even in actively 
treated patients the results were poor with 69% having an unfavorable outcome at 
three months. Active treatment seemed to reduce mortality: the mortality rate at 
three months was 68% for the conservatively and 30% for the actively treated 
patients. In elderly patients, active treatment seems prevent deaths without 
reducing the risk of unfavorable outcome. 
 
4.9 Endovascular and microneurosurgical treatment 
In many neurosurgical centers, endovascular management is now the treatment of 
choice in aSAH and it has been suggested to improve outcome after aSAH, 
especially in the elderly (4). However, Karamanakos et al. showed in a 
retrospective study that the introduction of endovascular treatment did not affect 
outcome in elderly aSAH patients (30,31). In our study, we could not reliably 
compare treatment outcome in coiled and clipped elderly patients because the 
number of coiled patients was small and the two groups differed in several key 
parameters. In our opinion, the main determinants for outcome in the elderly aSAH 
patient are the severity of the hemorrhage and the initial clinical grade. The 
method of treatment is of secondary importance and the decision between coiling 
or clipping should be made on an individual basis in order to minimize procedure -
related risk. 
 
4.10 Limitations of this study 
The fact that this study was retrospective in design causes some limitations. 
Patients were recruited over a prolonged period of time during which the attitude 
of treatment changed from conservative to active. Data was incomplete especially 
for smoking, alcohol abuse and long term follow-up. In our opinion, a short term 
follow-up is sufficient to make conclusions about aSAH in the elderly.  
It is controversial how to treat incidentally found unruptured aneurysms in the 
elderly (16). Also, it is still difficult to predict which elderly patients will not 
benefit from active treatment since even poor grade patients can sometimes 
achieve favorable outcome. As the consequences of aneurysm rupture in the 
elderly patients are catastrophic even when actively treated, aneurysms should 
ideally be treated before rupture at a younger age. In our opinion, research should 
be focused on prevention of aneurysm formation and early detection of 
unruptured aneurysms followed by preventive treatment in order to avoid aSAH 
altogether. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 Conclusion 
The number of elderly aSAH patients is increasing. Their treatment outcome is 
often unfavorable despite active treatment. The main determinants of outcome are 
the severity of the subarachnoid hemorrhage and the initial clinical grade. Active 
treatment of elderly aSAH patients seems to prevent deaths without reducing the 
risk of unfavorable outcome. Patients with WFNS grade I are the best candidates 
for treatment with a 50% chance of favorable outcome. Poor initial clinical grade 
can be regarded as a relative contraindication for active treatment. In our study, 
the outcome of all patients aged ≥85 years was unfavorable. 
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